Fulcrum Therapeutics, Inc. - Common Stock (FULC)

Fulcrum Therapeutics Inc is a biopharmaceutical company focused on developing innovative therapies for serious genetic diseases

The company leverages its proprietary drug discovery platform to address the underlying causes of these conditions, particularly in diseases caused by gene mutations and epigenetic factors. By targeting specific pathways and mechanisms, Fulcrum aims to create treatments that significantly improve the quality of life for patients affected by these challenging disorders. Its commitment to scientific innovation and collaboration with the medical community drives the advancement of potential therapies from preclinical stages through clinical development.